Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
certolizumab pegol | tumor necrosis factor | biotech | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Cells[MeSHID:D002477] Maintenance[MeSHID:D008283] Inflammation[MeSHID:D007249] Cell Differentiation process[MeSHID:D002454] Continuance of life[MeSHID:D013534] Senile Plaques[MeSHID:D058225] Signal Transduction[MeSHID:D015398] Arthritis Psoriatic[MeSHID:D015535] Psoriasis[MeSHID:D011565] Disease[MeSHID:D004194] Body tissue[MeSHID:D014024] Ankylosing spondylitis[MeSHID:D013167] Rheumatoid Arthritis[MeSHID:D001172] Spondylarthritis[MeSHID:D025241] Cell Death[MeSHID:D016923] Dental Plaque[MeSHID:D003773] |
NA | approved | neutralizer |
certolizumab pegol | tumor necrosis factor | biotech | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Cells[MeSHID:D002477] Maintenance[MeSHID:D008283] Inflammation[MeSHID:D007249] Cell Differentiation process[MeSHID:D002454] Continuance of life[MeSHID:D013534] Senile Plaques[MeSHID:D058225] Signal Transduction[MeSHID:D015398] Arthritis Psoriatic[MeSHID:D015535] Psoriasis[MeSHID:D011565] Disease[MeSHID:D004194] Body tissue[MeSHID:D014024] Ankylosing spondylitis[MeSHID:D013167] Rheumatoid Arthritis[MeSHID:D001172] Spondylarthritis[MeSHID:D025241] Cell Death[MeSHID:D016923] Dental Plaque[MeSHID:D003773] |
0.94 | approved | neutralizer,inhibitor |
click here to return to the previous page |